Status:
TERMINATED
Orphenadrine Versus Baclofen in Treatment of Muscle Cramps in Cirrhotic Patients
Lead Sponsor:
Mansoura University
Conditions:
Cirrhosis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Muscle cramps are commonly affects patients with cirrhosis. It adversely influences the quality of life of cirrhotic patients. Treatment of muscle cramps still challenging owing to the diversity of th...
Eligibility Criteria
Inclusion
- Age 18-70 years
- Cirrhotic patients complaining of frequent muscle cramps (\>3 per week) for at least a month
Exclusion
- Patients with allergy to study drugs
- Renal impairment
- Peripheral vascular disease
- Peripheral neuropathy
- Glaucoma
- Prostatic enlargement
- Pregnancy and lactation
- Patients taking calcium channel blockers, and conjugated estrogens
- Patients taking vitamin E, taurine, carnitine, narcotic pain medications, muscle relaxants, nonsteroidal anti-inflammatory drugs, or antispastic agents during and for 2 weeks following the study
- Patients with alcoholic cirrhosis
Key Trial Info
Start Date :
August 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 20 2021
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04509336
Start Date
August 20 2020
End Date
September 20 2021
Last Update
April 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University Hospitals
Tanta, Egypt